Exploring the use and effects of ketamine in medical and recreational contexts
Investigating the Ketamine Landscape: Availability, Medical and Recreational Use, and Effects
This study looks at how ketamine is being used for treating depression and as a recreational drug, focusing on its safety and effectiveness, so that patients can better understand its risks and benefits.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11061801 on NIH RePORTER |
What this research studies
This research investigates the increasing use of ketamine, both as a prescribed medication for conditions like depression and as a recreational drug. It aims to gather data on prescribing practices, medical and nonmedical use, and the associated risks such as poisonings and adverse events. By analyzing trends in the New York City tristate area, the study seeks to understand how media and cultural perceptions influence ketamine's use. Patients may benefit from insights into the safety and efficacy of ketamine treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 21 and older who are either prescribed ketamine for medical purposes or are involved in recreational use.
Not a fit: Patients who are under 21 years old or those who do not use ketamine in any form may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide valuable information on the safe use of ketamine and help mitigate risks associated with its misuse.
How similar studies have performed: Previous research has shown promising results in understanding the effects of ketamine, but this study aims to provide a comprehensive view of both medical and recreational use, making it a novel approach.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Palamar, Joseph J — New York University School of Medicine
- Study coordinator: Palamar, Joseph J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.